Resources to help get your patients started on VYJUVEK
Filling out this form is the first step toward VYJUVEK treatment. It is the prescription form for VYJUVEK and enables patient enrollment into Krystal Connect.Download Now
This guide provides general information on coding, coverage, billing, and reimbursement for VYJUVEK.Download Now
A template you can use to request VYJUVEK prior to it being on formulary.Download Now
A template you can use as a reference when writing a Letter of Medical Necessity to your patient's insurance company.Download Now
This checklist will help navigate the process of submitting a Prior Authorization for VYJUVEK, should one be required.Download Now
Information about the preparation and administration of VYJUVEK
A brochure with step-by-step guidance on how to prepare VYJUVEK for administration.Download Now
This brochure provides instructions on how to properly administer VYJUVEK to patients.Download Now
See the steps necessary to mix and prepare VYJUVEK.
Watch a step-by-step demonstration of how to administer VYJUVEK to your patient's DEB wounds.
Helpful information to share with your patients or their caregivers about VYJUVEK and DEB
Information about VYJUVEK for DEB patients and their caregivers.Download Now
Introduction to support services available to patients and their caregivers through Krystal Connect.Download Now
This tool can be shared with patients who are trying to find a doctor in their area who treats DEB.Find a Doctor
Hear about real-world experience with VYJUVEK
VYJUVEK is a topical gel indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII (COL7A1) gene.
WARNINGS AND PRECAUTIONS
Accidental Exposure to VYJUVEK gel: VYJUVEK will not replicate in the subject’s cells and does not integrate into the subject cells’ native genetic material. For precautions, avoid direct contact with treated wounds (e.g., touching or scratching) and dressings of treated wounds for approximately 24 hours following treatment. Wear protective gloves when assisting subjects with changing wound dressings and handling the disposal. In the event of accidental exposure (e.g., through a splash to the eyes or mucous membranes), flush with clean water for at least 15 minutes.
Clean all surfaces that may have come in contact with VYJUVEK biological suspension or gel and treat all spills with a virucidal agent.
Dispose all materials (e.g., vial, syringe, needle, cleaning materials) that may have come in contact with VYJUVEK biological suspension or gel into a biohazard bag or container.ADVERSE REACTIONS
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose.
- Please see Important Safety Information above and click here for full Prescribing Information.
For US Healthcare Professionals Only
This website is intended for US healthcare professionals.
Would you like to continue?
You are about to leave the VYJUVEKHCP.com website
Are you sure you want to leave?